# QIAGEN N.V. to release results for Q3 2024 and hold webcast
Canonical URL: https://biopharmsignal.com/news/QGEN/qiagen-n-v-to-release-results-for-q3-2024-and-hold-webcast-e6d509a4
Ticker: QGEN
Company: Qiagen N.V.
Source: Qiagen N.V.
Published: 2024-10-10 11:41 EST
## Summary

QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for...

## Article Body
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the third quarter 2024.

Press release date / time: Wednesday, November 6 , shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time.

Conference call date / time: Thursday, November 7 , at 15:30 Frankfurt time / 14:30 London time / 09:30 New York time.

Three options for joining the conference call

Register for call back connection - Click here: Connect me Service is available 15 minutes before the call starts

Dial-in by phone U.S.: +1 929 477 0448 UK: +44 (0)330 165 3655 GER: +49 (0)69 6610 2492 Conference ID: 8002609 To avoid waiting time, please join the event conference 5-10 minutes prior to the start time.

Access the audio webcast - Click here: Access Webcast

A conference call replay will be available by using the following link: https://event.webcasts.com/starthere.jsp?ei=1675519&tp_key=f8f77655ec

Contact : IR@qiagen.com

About QIAGEN

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). As of June 30, 2024, QIAGEN employed more than 5,900 people in over 35 locations worldwide. Further information can be found at https://www.qiagen.com .

source: QIAGEN N.V. category: Financial
## Recent Company News
- 2024-11-27 21:05 EST — [QIAGEN führt neuartige Tools zur Anpassung von digitalen PCR‑Assays und NGS-Panels für die mikrobielle Analyse ein](https://biopharmsignal.com/news/QGEN/qiagen-f-hrt-neuartige-tools-zur-anpassung-von-digitalen-pcr-assays-und-ngs-pane-a242cf6d) — Source: Qiagen N.V.
- 2024-11-27 21:05 EST — [QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis](https://biopharmsignal.com/news/QGEN/qiagen-launches-novel-tools-for-customizing-digital-pcr-assays-and-ngs-panels-fo-1dbf1806) — Source: Qiagen N.V.
- 2024-11-12 21:05 EST — [QIAGEN und McGill University starten Partnerschaft zur Förderung der Mikrobiomforschung](https://biopharmsignal.com/news/QGEN/qiagen-und-mcgill-university-starten-partnerschaft-zur-f-rderung-der-mikrobiomfo-d8ea3ab3) — Source: Qiagen N.V.
- 2024-11-12 21:05 EST — [QIAGEN collaborates with McGill University to advance microbiome research](https://biopharmsignal.com/news/QGEN/qiagen-collaborates-with-mcgill-university-to-advance-microbiome-research-98e08ed5) — Source: Qiagen N.V.
- 2024-11-06 21:32 EST — [QIAGEN übertrifft Prognose für drittes Quartal 2024 mit solidem Wachstum und erhöht Jahresprognose für bereinigten Gewinn je Aktie](https://biopharmsignal.com/news/QGEN/qiagen-bertrifft-prognose-f-r-drittes-quartal-2024-mit-solidem-wachstum-und-erh--933db05e) — Source: Qiagen N.V.
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)